Literature DB >> 18024694

A novel phenotype of sporadic Creutzfeldt-Jakob disease.

G Giaccone1, G Di Fede, M Mangieri, L Limido, R Capobianco, S Suardi, M Grisoli, S Binelli, P Fociani, O Bugiani, F Tagliavini.   

Abstract

An atypical case of sporadic Creutzfeldt-Jakob disease (CJD) is described in a 78-year-old woman homozygous for methionine at codon 129 of the prion protein (PrP) gene. The neuropathological signature was the presence of PrP immunoreactive plaque-like deposits in the cerebral cortex, striatum and thalamus. Western blot analysis showed a profile of the pathological form of PrP (PrP(Sc)) previously unrecognised in sporadic CJD, marked by the absence of diglycosylated protease resistant species. These features define a novel neuropathological and molecular CJD phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18024694      PMCID: PMC2095610          DOI: 10.1136/jnnp.2007.115444

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

1.  Creutzfeldt-Jakob disease: Carnoy's fixative improves the immunohistochemistry of the proteinase K-resistant prion protein.

Authors:  G Giaccone; B Canciani; G Puoti; G Rossi; D Goffredo; S Iussich; P Fociani; F Tagliavini; O Bugiani
Journal:  Brain Pathol       Date:  2000-01       Impact factor: 6.508

2.  Creutzfeldt-Jakob disease with a novel four extra-repeat insertional mutation in the PrP gene.

Authors:  G Rossi; G Giaccone; L Giampaolo; S Iussich; G Puoti; M Frigo; G Cavaletti; L Frattola; O Bugiani; F Tagliavini
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

3.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.

Authors:  J D Wadsworth; S Joiner; A F Hill; T A Campbell; M Desbruslais; P J Luthert; J Collinge
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

4.  Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.

Authors:  P Parchi; A Giese; S Capellari; P Brown; W Schulz-Schaeffer; O Windl; I Zerr; H Budka; N Kopp; P Piccardo; S Poser; A Rojiani; N Streichemberger; J Julien; C Vital; B Ghetti; P Gambetti; H Kretzschmar
Journal:  Ann Neurol       Date:  1999-08       Impact factor: 10.422

5.  The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis.

Authors:  M E Bruce; I McConnell; H Fraser; A G Dickinson
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

6.  Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes.

Authors:  Gianluigi Zanusso; Alessia Farinazzo; Frances Prelli; Michele Fiorini; Matteo Gelati; Sergio Ferrari; Pier Giorgio Righetti; Nicolò Rizzuto; Blas Frangione; Salvatore Monaco
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

Review 7.  Gerstmann-Sträussler-Scheinker disease and the Indiana kindred.

Authors:  B Ghetti; S R Dlouhy; G Giaccone; O Bugiani; B Frangione; M R Farlow; F Tagliavini
Journal:  Brain Pathol       Date:  1995-01       Impact factor: 6.508

8.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

Review 9.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues.

Authors:  A Jiménez-Huete; P M Lievens; R Vidal; P Piccardo; B Ghetti; F Tagliavini; B Frangione; F Prelli
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

View more
  5 in total

1.  Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein.

Authors:  Wen-Quan Zou; Gianfranco Puoti; Xiangzhu Xiao; Jue Yuan; Liuting Qing; Ignazio Cali; Miyuki Shimoji; Jan P M Langeveld; Rudy Castellani; Silvio Notari; Barbara Crain; Robert E Schmidt; Michael Geschwind; Stephen J Dearmond; Nigel J Cairns; Dennis Dickson; Lawrence Honig; Juan Maria Torres; James Mastrianni; Sabina Capellari; Giorgio Giaccone; Ermias D Belay; Lawrence B Schonberger; Mark Cohen; George Perry; Qingzhong Kong; Piero Parchi; Fabrizio Tagliavini; Pierluigi Gambetti
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

2.  A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report.

Authors:  Ana B Rodríguez-Martínez; Joseba M Garrido; Juan J Zarranz; Jose M Arteagoitia; Marian M de Pancorbo; Begoña Atarés; Miren J Bilbao; Isidro Ferrer; Ramón A Juste
Journal:  BMC Neurol       Date:  2010-10-25       Impact factor: 2.474

3.  Further Characterization of Glycoform-Selective Prions of Variably Protease-Sensitive Prionopathy.

Authors:  Weiguanliu Zhang; Xiangzhu Xiao; Mingxuan Ding; Jue Yuan; Aaron Foutz; Mohammed Moudjou; Tetsuyuki Kitamoto; Jan P M Langeveld; Li Cui; Wen-Quan Zou
Journal:  Pathogens       Date:  2021-04-23

Review 4.  Prions in variably protease-sensitive prionopathy: an update.

Authors:  Wen-Quan Zou; Pierluigi Gambetti; Xiangzhu Xiao; Jue Yuan; Jan Langeveld; Laura Pirisinu
Journal:  Pathogens       Date:  2013-07-05

5.  Glycoform-selective prion formation in sporadic and familial forms of prion disease.

Authors:  Xiangzhu Xiao; Jue Yuan; Stéphane Haïk; Ignazio Cali; Yian Zhan; Mohammed Moudjou; Baiya Li; Jean-Louis Laplanche; Hubert Laude; Jan Langeveld; Pierluigi Gambetti; Tetsuyuki Kitamoto; Qingzhong Kong; Jean-Philippe Brandel; Brian A Cobb; Robert B Petersen; Wen-Quan Zou
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.